You are here

Electrophysiology & Arrhythmia

 

Patients with atrial fibrillation and at least one additional risk factor for stroke who received digoxin had higher mortality rates compared with those who did not take digoxin, according to an analysis of a randomized trial.

Nearly 85 percent of patients with a history of atrial fibrillation who had an acute ischemic stroke did not receive guideline-recommended anticoagulation or had anticoagulation levels that did not fall in the therapeutic range, according to a registry analysis.

CMS has approved coverage of Medtronic’s Micra transcatheter pacing system for patients who need a single-chamber pacemaker.

The FDA granted premarket approval to Zoll Corporation’s hospital wearable defibrillator.

Between 1999 and 2013, the adjusted rates of hospitalization for atrial fibrillation increased nearly 1 percent year per year among Medicare fee-for-service beneficiaries, while the median Medicare inpatient expenditure per beneficiary increased from $2,932 to $4,719 per stay.

 

Recent Headlines

Phillips recalls 47,000 units of its HeartStart MRx monitor/defibrillator

Phillips recalled the HeartStart MRx monitor/defibrillator after discovering electrical and battery connection issues that could prevent the device from powering up, charging and delivering an electrical shock therapy.

BioSig Technologies agrees to partnership with two Mayo Clinic electrophysiologists

BioSig Technologies announced an agreement to work with two Mayo Clinic cardiac electrophysiologists to develop features and applications for the company’s PURE EP system.

ACC.17: Digoxin use may increase the risk of death in patients with atrial fibrillation

Patients with atrial fibrillation and at least one additional risk factor for stroke who received digoxin had higher mortality rates compared with those who did not take digoxin, according to an analysis of a randomized trial.

85% of atrial fibrillation patients receive inadequate anticoagulation prior to stroke

Nearly 85 percent of patients with a history of atrial fibrillation who had an acute ischemic stroke did not receive guideline-recommended anticoagulation or had anticoagulation levels that did not fall in the therapeutic range, according to a registry analysis.

Medtronic’s new cardiac monitor receives FDA approval

The U.S. Food and Drug Administration (FDA) approvead Medtronic’s Reveal LINQ Insertable Cardiac Monitor with TruRhythm Detection, designed to accurately identify abnormal heartbeats.

CMS approves coverage for Medtronic’s Micra transcatheter pacing system

CMS has approved coverage of Medtronic’s Micra transcatheter pacing system for patients who need a single-chamber pacemaker.

FDA grants premarket approval to Zoll’s hospital wearable defibrillator

The FDA granted premarket approval to Zoll Corporation’s hospital wearable defibrillator.

FDA approves ablation catheter for patients with atrial flutter

The FDA approved the FlexAbility Ablation Catheter, Sensor Enabled for patients with atrial flutter.

Electromagnetic interference may occur in patients with pacemakers

Patients with pacemakers may experience harmful electromagnetic interference caused by power lines, household appliances, electric tools and entertainment electronics, according to an in vivo study.

Medtronic receives CE Mark for CRT pacemakers

Medtronic announced Feb. 24 that the company had received CE marks for quadripolar cardiac resynchronization therapy (CRT) pacemakers that allow patients to receive MRIs.

Pages